Skip to main content
Top
Published in: World Journal of Surgery 1/2021

01-01-2021 | Carcinoid Tumor | Surgical Symposium Contribution

Surgical Management of Primary Small Bowel NET Presenting Acutely with Obstruction or Perforation

Published in: World Journal of Surgery | Issue 1/2021

Login to get access

Abstract

Up to 35% of small bowel neuroendocrine tumors (SBNETs) may present with an acute intra-abdominal complication including obstruction, perforation, bleeding or ischemia and may require emergency surgical treatment in centers not normally accustomed to managing patients with neuroendocrine tumors. These patients may have a known diagnosis of SBNET, be suspected as suffering from SBNET or have SBNET diagnosed as an incidental finding on presenting radiology or postoperative pathology. Perioperative priorities include obtaining both clinical and radiological staging with cross-sectional imaging and clinical examination, screening for the presence of carcinoid syndrome and right-sided cardiac disease and assessment of prognosis. Intraoperatively careful attention should be paid to noting the presence and location of multifocal primary and metastatic disease. Ideally, surgical resection with mesenteric lymph node dissection is the treatment of choice for obstructing and perforating lesions. Extended lymphadenectomy along the SMA, SMV and behind the pancreas should be primarily considered an elective procedure. In unwell patients with advanced disease surgical bypass (jejuno or ileocolic) or proximal defunctioning should be undertaken but, given the excellent long-term survivals in patients with stage IV disease, could be considered bridging procedures to elective resection following formal staging and multidisciplinary review.
Literature
1.
go back to reference Yao JC, Hassan M, Phan A et al (2008) One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063–3072CrossRef Yao JC, Hassan M, Phan A et al (2008) One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063–3072CrossRef
2.
go back to reference Abou Saleh M, Mansoor E, Anindo M et al (2019) Prevalence of small intestine carcinoid tumors: a US population-based study 2012–2017. Dig Dis Sci 64:1328–1334CrossRef Abou Saleh M, Mansoor E, Anindo M et al (2019) Prevalence of small intestine carcinoid tumors: a US population-based study 2012–2017. Dig Dis Sci 64:1328–1334CrossRef
3.
go back to reference Manguso N, Gangi A, Nissen N et al (2018) Long-term outcomes after elective versus emergency surgery for small bowel neuroendocrine tumors. Am Surg 84(10):1570–1574CrossRef Manguso N, Gangi A, Nissen N et al (2018) Long-term outcomes after elective versus emergency surgery for small bowel neuroendocrine tumors. Am Surg 84(10):1570–1574CrossRef
4.
go back to reference Landry CS, Brock G, Scoggins CR et al (2008) A proposed staging system for small bowel carcinoid tumors based on the analysis of 6380 patients. Am J Surg 196:896–903 discussion 903CrossRef Landry CS, Brock G, Scoggins CR et al (2008) A proposed staging system for small bowel carcinoid tumors based on the analysis of 6380 patients. Am J Surg 196:896–903 discussion 903CrossRef
5.
go back to reference Howe JR, Cardona K, Fraker DL et al (2017) The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the north american neuroendocrine tumor society. Pancreas 46(6):715–731CrossRef Howe JR, Cardona K, Fraker DL et al (2017) The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the north american neuroendocrine tumor society. Pancreas 46(6):715–731CrossRef
6.
go back to reference Akerstrom G, Hellman P, Hessman O et al (2005) Management of midgut carcinoids. J Surg Oncol 89:161–169CrossRef Akerstrom G, Hellman P, Hessman O et al (2005) Management of midgut carcinoids. J Surg Oncol 89:161–169CrossRef
7.
go back to reference Tolstrup M, Watt SK, Gögenur I (2017) Morbidity and mortality rates after emergency abdominal surgery: an analysis of 4346 patients scheduled for emergency laparotomy or laparoscopy. Langenbecks Arch Surg 402:615–623CrossRef Tolstrup M, Watt SK, Gögenur I (2017) Morbidity and mortality rates after emergency abdominal surgery: an analysis of 4346 patients scheduled for emergency laparotomy or laparoscopy. Langenbecks Arch Surg 402:615–623CrossRef
8.
go back to reference Watzka FM, Fottner C, Miederer M et al (2016) Surgical treatment of NEN of small bowel: a retrospective analysis. World J Surg 40(3):749–758CrossRef Watzka FM, Fottner C, Miederer M et al (2016) Surgical treatment of NEN of small bowel: a retrospective analysis. World J Surg 40(3):749–758CrossRef
9.
go back to reference Pasquer A, Walter T, Hervieu V et al (2015) Surgical management of small bowel neuroendocrine tumors: specific requirements and their impact on staging and prognosis. Ann Surg Oncol 22(3):742–749CrossRef Pasquer A, Walter T, Hervieu V et al (2015) Surgical management of small bowel neuroendocrine tumors: specific requirements and their impact on staging and prognosis. Ann Surg Oncol 22(3):742–749CrossRef
10.
go back to reference Eriksson J, Garmo H, Hellman P et al (2017) The influence of preoperative symptoms on the death of patients with small intestinal neuroendocrine tumours. Ann Surg Oncol 24:1214–1220CrossRef Eriksson J, Garmo H, Hellman P et al (2017) The influence of preoperative symptoms on the death of patients with small intestinal neuroendocrine tumours. Ann Surg Oncol 24:1214–1220CrossRef
11.
go back to reference Boudreaux JP, Putty B, Frey DJ et al (2005) Surgical treatment of advanced-stage carcinoid tumors: lessons learned. Ann Surg 241(6):839–845CrossRef Boudreaux JP, Putty B, Frey DJ et al (2005) Surgical treatment of advanced-stage carcinoid tumors: lessons learned. Ann Surg 241(6):839–845CrossRef
12.
go back to reference Erikssin B, Kloppel G, Krenning E et al (2008) Consensus guidelines for the management of patients with digestive neuroendocrine tumors – well differentiated jejunal-ileal tumor/carcinoma. Neuroendocrinology 87:8–19CrossRef Erikssin B, Kloppel G, Krenning E et al (2008) Consensus guidelines for the management of patients with digestive neuroendocrine tumors – well differentiated jejunal-ileal tumor/carcinoma. Neuroendocrinology 87:8–19CrossRef
15.
go back to reference Woodbridge LR, Murtagh BM, Yu DF et al (2014) Midgut neuroendocrine tumors: imaging assessment for surgical resection. Radiographics 34(2):413–426CrossRef Woodbridge LR, Murtagh BM, Yu DF et al (2014) Midgut neuroendocrine tumors: imaging assessment for surgical resection. Radiographics 34(2):413–426CrossRef
16.
go back to reference Sahani DV, Bonaffini PA, Fernández-Del Castillo C et al (2013) Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 266(1):38–61CrossRef Sahani DV, Bonaffini PA, Fernández-Del Castillo C et al (2013) Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 266(1):38–61CrossRef
17.
go back to reference Moertel CG (1983) Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol 1(11):727–740CrossRef Moertel CG (1983) Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol 1(11):727–740CrossRef
18.
go back to reference Curan T, Tulin-Silver S, Patel K et al (2011) Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors. Pancreas 40:1253–1257CrossRef Curan T, Tulin-Silver S, Patel K et al (2011) Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors. Pancreas 40:1253–1257CrossRef
19.
go back to reference Stueven AK, Kayser A, Wetz C et al (2019) Somatostatin analgues in the treatment of neuroendocrine tumors: past, present and future. Int J Molecular Science 120(12):167–181 Stueven AK, Kayser A, Wetz C et al (2019) Somatostatin analgues in the treatment of neuroendocrine tumors: past, present and future. Int J Molecular Science 120(12):167–181
20.
go back to reference Perry D, Hayek SS (2019) Carcinoid heart disease: a guide for clinicians. Cardiol Clin 37(4):497–503CrossRef Perry D, Hayek SS (2019) Carcinoid heart disease: a guide for clinicians. Cardiol Clin 37(4):497–503CrossRef
21.
go back to reference Pape U-F, Perren A, Niederle B et al (2012) ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinoids. Neuroendocrinology 95:125–156CrossRef Pape U-F, Perren A, Niederle B et al (2012) ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinoids. Neuroendocrinology 95:125–156CrossRef
22.
go back to reference Zandee WT, de Herder WW (2018) The evolution of neuroendocrine tumor treatment reflected by ENETS guidelines. Neuroendocrinology 106(4):357–365CrossRef Zandee WT, de Herder WW (2018) The evolution of neuroendocrine tumor treatment reflected by ENETS guidelines. Neuroendocrinology 106(4):357–365CrossRef
24.
go back to reference Weber DG, Bendinelli C, Balogh ZJ (2014) Damage control surgery for abdominal emergencies. Br J Surg 101(1):e109–e118CrossRef Weber DG, Bendinelli C, Balogh ZJ (2014) Damage control surgery for abdominal emergencies. Br J Surg 101(1):e109–e118CrossRef
25.
go back to reference Partelli S, Bartsch DK, Capdevila J et al (2017) ENETS consensus guidelines for the standards of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology 105:255–265CrossRef Partelli S, Bartsch DK, Capdevila J et al (2017) ENETS consensus guidelines for the standards of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology 105:255–265CrossRef
26.
go back to reference Boudreaux JP, Klimstra DS, Hassan MM et al (2010) The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum. Pancreas 39(6):753–766CrossRef Boudreaux JP, Klimstra DS, Hassan MM et al (2010) The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum. Pancreas 39(6):753–766CrossRef
27.
go back to reference Younes M (2005) Frozen section of the gastrointestinal tract, appendix, and peritoneum. Arch Pathol Lab Med 129(12):1558–1564PubMed Younes M (2005) Frozen section of the gastrointestinal tract, appendix, and peritoneum. Arch Pathol Lab Med 129(12):1558–1564PubMed
28.
go back to reference Laskaratos FM, Diamantopoulos L, Walker M et al (2018) Prognostic factors for survival among patients with small bowel neuroendocrine tumours associated with mesenteric desmoplasia. Neuroendocrinology 1:1–15 Laskaratos FM, Diamantopoulos L, Walker M et al (2018) Prognostic factors for survival among patients with small bowel neuroendocrine tumours associated with mesenteric desmoplasia. Neuroendocrinology 1:1–15
Metadata
Title
Surgical Management of Primary Small Bowel NET Presenting Acutely with Obstruction or Perforation
Publication date
01-01-2021
Published in
World Journal of Surgery / Issue 1/2021
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05689-7

Other articles of this Issue 1/2021

World Journal of Surgery 1/2021 Go to the issue